NAD, the Key to Aging: Making Sense of NMN and NAD IV Therapy

💡 Key Takeaways

· NAD (coenzyme I) is a core coenzyme in every cell, driving energy metabolism, DNA repair, and aging regulation. It declines to roughly half its level between your 20s and 50s.

· When NAD drops, sirtuins (aging-regulating proteins) and PARPs (DNA-repair enzymes) lose function, leading to collagen breakdown, fine lines, and loss of elasticity.

· The most evidence-backed way to replenish NAD is oral NMN. Taking 250 mg daily for 12 weeks significantly raised blood NAD levels (Igarashi et al., 2022).

· NAD IV therapy is popular, but even when infused, the rise in blood NAD is limited and infusion discomfort is common—so its efficiency is debated.

· Lifestyle factors—exercise, sleep, and sun protection—also directly help preserve NAD.

NAD (NAD+, Nicotinamide Adenine Dinucleotide, coenzyme I) is a coenzyme—a helper molecule that enzymes need to work—found in every living cell in the body. Often called "the switch of aging" in anti-aging circles, it has driven rapid interest in NMN supplements and NAD IV therapy. Yet the information on how to choose between them is muddled. This article explains why NAD matters for aging and skin, and reviews three approaches in light of the current evidence.

Why NAD is directly tied to skin aging

NAD matters not just for producing energy, but because two types of enzymes that directly regulate aging use NAD as fuel.

The first is the sirtuin family. Sirtuins such as SIRT1 and SIRT6 are 'NAD-dependent proteins'—they only work when NAD is present. They suppress MMP-1, the enzyme that breaks down collagen, thereby protecting the collagen that underpins skin elasticity, and they help calm inflammatory signaling (NF-κB).

The second is PARP, a group of DNA-repair enzymes. Skin DNA is damaged daily by UV, pollution, and oxidative stress, and PARP repairs that damage immediately. But PARP also consumes NAD as it works, so when NAD is scarce, repair slows and damage accumulates.

The problem is that NAD declines with age. Studies report that human cellular NAD falls to roughly half between the 20s and 50s. As NAD drops, sirtuin activity falls and DNA repair slows, ultimately driving cellular senescence (accumulation of aged cells) and chronic inflammation ("inflammaging"). Worse, inflammation activates an enzyme called CD38 that consumes NAD even faster, creating a vicious cycle: 'less NAD → inflammation → even less NAD' (as summarized in a Nadis Academy review, 2025). The fact that topical cosmetics alone struggle to address this internal energy-and-repair problem is exactly why NAD replenishment has drawn attention.

Approach 1. Oral NMN supplements — the strongest current evidence

NMN (nicotinamide mononucleotide) is the immediate precursor of NAD—the raw material the body converts into NAD. Of the three approaches, it has the most accumulated human clinical evidence.

• In a randomized, double-blind trial in healthy older men, taking NMN 250 mg/day for 6–12 weeks significantly raised blood NAD and its metabolites, with trends toward improvement in some measures like gait speed and grip strength (Igarashi et al., 2022, npj Aging).
• A 2025 human comparison study in Nature Metabolism found that 14 days of NMN or NR (another precursor) roughly doubled blood NAD, whereas plain nicotinamide did not (Christen et al., 2025).
• On safety, a trial giving healthy adults NMN 1,250 mg/day for 4 weeks reported no serious adverse events (2022, randomized placebo-controlled study).

That said, there are limits worth stating honestly. Large-scale trials directly measuring NMN's skin-improvement effects are still lacking; current evidence combines the fact that it 'raises blood NAD' with inference via the sirtuin/PARP mechanisms above. A meta-analysis also found no clear statistical benefit on metabolic markers like glucose and lipids in healthy adults (2024, 8 RCTs pooled). In short, NMN is a 'validated tool for steadily replenishing NAD,' but how much benefit you feel varies widely between individuals.

Approach 2. NAD IV therapy — the gap between popularity and evidence

NAD IV therapy—delivering NAD directly into a vein to replenish it quickly—has become popular mainly through wellness clinics. It seems the most powerful intuitively, but recent human studies show it isn't that simple.

The NAD molecule is large and doesn't readily enter cells directly. In one human comparison study, NAD IV raised blood NAD by only about 2% and not until 24 hours after infusion, whereas NR IV rose by about 20% within 3 hours (2026, retrospective pilot study). The NAD IV group also showed changes such as increased white blood cell and neutrophil counts, markers that may suggest an inflammatory response.

In terms of experience, fast NAD infusions commonly cause discomfort—burning sensation, nausea, chest pressure—so they must be given slowly (typically tens of minutes to a few hours). The U.S. FDA has warned about contamination and quality risks with some compounded NAD injectables. A 2020 systematic review noted that randomized trials of NAD infusion therapy are few and the evidence is "promising yet still speculative."

In summary, NAD IV therapy can be a reasonable option when fast replenishment is needed or oral absorption is difficult, but the notion that 'IV delivery is automatically more efficient' is not supported by current evidence. For skin and anti-aging purposes, it's best to decide after being fully informed about expected effects, infusion discomfort, and the cost-versus-evidence picture.

Approach 3. Lifestyle — the most underrated NAD management

Before supplements or IVs, there are lifestyle habits that help the body consume less NAD and make more. Regular aerobic exercise stimulates NAD-synthesis pathways, and adequate sleep and caloric restriction (including intermittent fasting) are reported to reduce NAD consumption. Above all, sun protection reduces the very DNA damage PARP must process—making it the most cost-effective 'NAD-saving' strategy.

The DIORE clinical principle

In our practice, we frame NAD management not as 'one treatment that does it all,' but as something built up in order of evidence strength. We first check the foundations—sun protection, sleep, exercise—then add the best-evidenced oral precursors (NMN/NR), and offer IV therapy only when fast replenishment is needed or oral isn't feasible, after fully explaining its expectations and limitations. Because individual response varies greatly with NAD, our principle is to advise within the current evidence, without exaggeration.

Frequently Asked Questions (Q&A)

Q1. How much NMN per day do I need for NAD to rise?

In human trials, 250 mg/day for 6–12 weeks significantly raised blood NAD, and up to 1,250 mg/day for 4 weeks was reported safe. There's little evidence that higher doses scale up benefits proportionally, so consistent intake generally matters more than short-term high doses. Please consult a medical professional about underlying conditions and medications before starting.

Q2. Is NAD IV faster and better than taking NMN?

Contrary to intuition, in human studies NAD IV produced only a limited rise in blood NAD (about 2% at 24 hours), while the precursor NR IV rose about 20% within 3 hours—because the NAD molecule doesn't readily enter cells directly. It's hard to claim IV is automatically superior.

Q3. Will NAD injections improve skin wrinkles or elasticity?

While it's mechanistically clear that NAD contributes to collagen protection and DNA repair via sirtuins and PARPs, skin trials directly proving that NAD injections improve wrinkles or elasticity are currently very limited. For cosmetic purposes, it helps to distinguish mechanistic expectation from actual evidence.

Q4. Which is better, NMN or NR?

Both roughly doubled blood NAD after 14 days in a human comparison study, so their efficiency at raising NAD appears similar (Christen et al., 2025). For IV delivery, there's data that NR raised NAD faster. Rather than one being absolutely superior, the choice depends on the absorption form and individual response.

Q5. Is it normal to feel nauseous or have chest tightness during an NAD IV?

Fast infusion commonly causes burning, nausea, and chest pressure, which is why slow infusion is standard. However, if symptoms are severe or persistent, tell your medical team immediately.

Conclusion

NAD is a core coenzyme linking aging and skin at the cellular level, and its decline with age is clear. But 'what to replenish it with' should be judged by the strength of the evidence, not by marketing. So far, lifestyle and oral precursors (NMN/NR) are the most validated foundation, while IV therapy is best chosen after being precisely informed of its expectations and limits. At DIORE Clinic, we design the management sequence by considering each person's skin condition and lifestyle together.

Recommended reads: Collagen and the science of skin elasticity, Anti-aging treatment comparison guide.

ℹ️ This content is provided for general medical information and does not replace individual consultation. The indications and precautions for supplements such as NMN and for IV therapy may vary by individual health status; for accurate diagnosis and consultation, please consult a qualified aesthetic medicine professional.

References

• Igarashi M, et al. (2022). Chronic NMN supplementation elevates blood NAD+ levels in healthy older men. npj Aging.
• Christen S, et al. (2025). Human comparison of NAD+ precursors. Nature Metabolism.
• β-NMN oral safety RCT (2022).
• NMN glucose/lipid meta-analysis (2024).
• NAD+ IV vs NR IV retrospective tolerability pilot (2026), Frontiers in Aging.
• NAD+ and skin aging mechanism review (Nadis Academy, 2025).